Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Chiarle

Showing results (101-110 of 156) with videos related to

Pageof 16
Sort By:
Cancer Research|September 7, 2014
ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasisCinzia Martinengo, Teresa Poggio, Matteo Menotti, et al.
Plos One|October 20, 2010
PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastomaTiziana Bachetti, Daniela Di Paolo, Simona Di Lascio, et al.
Leukemia & Lymphoma|May 24, 2011
Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjectsLudovica Riera, Elena Lasorsa, Lisa Bonello, et al.
Blood|August 18, 2005
p130Cas mediates the transforming properties of the anaplastic lymphoma kinaseChiara Ambrogio, Claudia Voena, Andrea D Manazza, et al.
Blood|April 27, 2011
The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathwayPaola Martinelli, Paola Bonetti, Cristina Sironi, et al.
Science Advances|August 29, 2025
IgM and IgG1 B cell receptors differentially affect B cell fates and dictate the pathogenesis of mature B cell lymphomasRebecca M Southern, Rebecca L Schmitz, Daniela Samaniego-Castruita, et al.
Developmental Cell|February 16, 2010
MT1-MMP is required for myeloid cell fusion via regulation of Rac1 signalingPilar Gonzalo, Marta C Guadamillas, María Victoria Hernández-Riquer, et al.
Cell|January 17, 2018
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRASChiara Ambrogio, Jens Köhler, Zhi-Wei Zhou, et al.
Oncotarget|December 2, 2016
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemiaValentina Griggio, Giorgia Mandili, Candida Vitale, et al.
Cell|October 4, 2011
Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cellsRoberto Chiarle, Yu Zhang, Richard L Frock, et al.
Pageof 16

Showing results (101-110 of 156) with videos related to

Sort By:
Pageof 16
Cancer Research|September 7, 2014
ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasisCinzia Martinengo, Teresa Poggio, Matteo Menotti, et al.
Plos One|October 20, 2010
PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastomaTiziana Bachetti, Daniela Di Paolo, Simona Di Lascio, et al.
Leukemia & Lymphoma|May 24, 2011
Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjectsLudovica Riera, Elena Lasorsa, Lisa Bonello, et al.
Blood|August 18, 2005
p130Cas mediates the transforming properties of the anaplastic lymphoma kinaseChiara Ambrogio, Claudia Voena, Andrea D Manazza, et al.
Blood|April 27, 2011
The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathwayPaola Martinelli, Paola Bonetti, Cristina Sironi, et al.
Science Advances|August 29, 2025
IgM and IgG1 B cell receptors differentially affect B cell fates and dictate the pathogenesis of mature B cell lymphomasRebecca M Southern, Rebecca L Schmitz, Daniela Samaniego-Castruita, et al.
Developmental Cell|February 16, 2010
MT1-MMP is required for myeloid cell fusion via regulation of Rac1 signalingPilar Gonzalo, Marta C Guadamillas, María Victoria Hernández-Riquer, et al.
Cell|January 17, 2018
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRASChiara Ambrogio, Jens Köhler, Zhi-Wei Zhou, et al.
Oncotarget|December 2, 2016
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemiaValentina Griggio, Giorgia Mandili, Candida Vitale, et al.
Cell|October 4, 2011
Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cellsRoberto Chiarle, Yu Zhang, Richard L Frock, et al.
Pageof 16